Physician profile
Anil M Parikh
NPI 1437218922
$293,229.72
in general payments reported to CMS, 2019-2025
9 companies · $9,866 in 2025
The $9,866 reported for 2025 was more than what 96% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69K · 2020: $33K · 2021: $24K · 2022: $16K · 2023: $91K · 2024: $50K · 2025: $9,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $124K · Travel and Lodging: $23K · Food and Beverage: $2,413 · Consulting Fee: $1,980 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $123,600.00 |
| Travel and Lodging | $23,245.70 |
| Food and Beverage | $2,412.54 |
| Consulting Fee | $1,980.00 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $189,310.93 | 2021-2025 | |
| Allergan, INC. | $101,814.22 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,994.41 | 2022-2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 2024 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $19.40 | 2019 | |
| Banner Life Sciences, LLC | $18.72 | 2022 | |
| Lundbeck LLC | $17.86 | 2022 | |
| Lantheus Medical Imaging, INC. | $16.28 | 2025 | |
| Neuronetics, INC. | $10.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.